Home › NCT07165860

Clinical Trial to Reduce Perinatal Intimate Partner Violence

Novel Doula Intervention to Leverage Clinic-community Connections to Support Perinatal Intimate Partner Violence Survivors

Who can join

Ages 18 and older · Women · Healthy volunteers welcome

Inclusion Criteria: Perinatal IPV survivors are eligible if they:

* 1\) feel comfortable completing the study in Spanish or English
* 2\) are age 18 or older
* 3\) are no more than 24 weeks 6 days gestation (note: participants enrolled earliest at 18 weeks, baseline at 22 weeks with a 3 week window)
* 4\) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV
* 5\) live within a 50 mile radius of Pittsburgh, Pennsylvania
* 6\) able to provide safe and complete contact information or take a study cell phone

Exclusion Criteria:

* Unable to consent
* Do not meet inclusion criteria
* Cannot provide safe contact information or take a study cell phone
* Incarcerated

About the study

This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors

What is being tested

• Doulas (behavioral)
• Thrive (behavioral)

Sponsor: University of Pittsburgh · Participants: 250 · Started: Nov 1, 2025

Contact the study team

• Maya Ragavan · Phone: 4126926545
• Maya Ragavan · Phone: 16506449954

Official record on ClinicalTrials.gov — NCT07165860

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.